{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:30:43Z","timestamp":1790865043480,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.mehy.2009.12.020","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T09:39:51Z","timestamp":1264066791000},"page":"1055-1058","source":"Crossref","is-referenced-by-count":17,"title":["Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell disease"],"prefix":"10.1016","volume":"74","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mehy.2009.12.020_bib1","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.freeradbiomed.2008.01.008","article-title":"Sickle cell disease vasculopathy: a state of nitric oxide resistance","volume":"44","author":"Wood","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2009.12.020_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassemia","author":"Morris","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.020_bib3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.mehy.2008.09.058","article-title":"High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals \u2013 clinical potential in inflammatory disorders","volume":"73","author":"McCarty","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2009.12.020_bib4","unstructured":"McCarty MF. The Oasis Executive Health Program. 2009. Ref Type: Unpublished Work."},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/jmf.2007.621","article-title":"Clinical potential of Spirulina as a source of phycocyanobilin","volume":"10","author":"McCarty","year":"2007","journal-title":"J Med Food"},{"issue":"13","key":"10.1016\/j.mehy.2009.12.020_bib6","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1096\/fj.04-2368fje","article-title":"Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats","volume":"19","author":"Lanone","year":"2005","journal-title":"FASEB J"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.12.020_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-006-9190-y","article-title":"Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction","volume":"291","author":"Matsumoto","year":"2006","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.020_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/01.HYP.0000242336.58387.1f","article-title":"NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells","volume":"48","author":"Jiang","year":"2006","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.020_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1096\/fj.04-3218fje","article-title":"Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice","volume":"19","author":"Wood","year":"2005","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1389203033487216","article-title":"C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects","volume":"4","author":"Romay","year":"2003","journal-title":"Curr Protein Pept Sci"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2009.12.020_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10284150600929748","article-title":"Spirulina maxima pretreatment partially protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity","volume":"9","author":"Chamorro","year":"2006","journal-title":"Nutr Neurosci"},{"issue":"19","key":"10.1016\/j.mehy.2009.12.020_bib13","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1021\/jf070529g","article-title":"Phycobiliprotein C-phycocyanin from Spirulina platensis is powerfully responsible for reducing oxidative stress and NADPH oxidase expression induced by an atherogenic diet in hamsters","volume":"55","author":"Riss","year":"2007","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0014-5793(03)01358-9","article-title":"Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity Identification of the antioxidant pharmacophore","volume":"555","author":"Rezk","year":"2003","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.020_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.106.612325","article-title":"5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling","volume":"114","author":"Antoniades","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.97.3.237","article-title":"5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia","volume":"97","author":"Verhaar","year":"1998","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.020_bib17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.RES.86.11.1129","article-title":"Folic acid reverts dysfunction of endothelial nitric oxide synthase","volume":"86","author":"Stroes","year":"2000","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.020_bib18","doi-asserted-by":"crossref","first-page":"H2167","DOI":"10.1152\/ajpheart.00935.2001","article-title":"Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function","volume":"282","author":"Hyndman","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.amjcard.2006.08.057","article-title":"Effect of folic acid on endothelial function following acute myocardial infarction","volume":"99","author":"Moens","year":"2007","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.020_bib20","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.freeradbiomed.2005.12.015","article-title":"Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction","volume":"40","author":"Wood","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2009.12.020_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.725481","article-title":"High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury","author":"Moens","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.020_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","article-title":"Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia","volume":"91","author":"Guzy","year":"2006","journal-title":"Exp Physiol"},{"issue":"4\u20135","key":"10.1016\/j.mehy.2009.12.020_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/13813450701661198","article-title":"The central role of glutathione in the pathophysiology of human diseases","volume":"113","author":"Franco","year":"2007","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2013a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.020_bib25","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"13","key":"10.1016\/j.mehy.2009.12.020_bib26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1055\/s-0028-1088302","article-title":"Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals","volume":"74","author":"Surh","year":"2008","journal-title":"Planta Med"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.020_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/jcb.22197","article-title":"Identification and characterization of an Nrf2-mediated ARE upstream of the rat glutamate cysteine ligase catalytic subunit gene (GCLC)","volume":"107","author":"Li","year":"2009","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1096-8652(199909)62:1<19::AID-AJH4>3.0.CO;2-C","article-title":"N-acetylcysteine and clotrimazole inhibit sickle erythrocyte dehydration induced by 1-chloro-2, 4-dinitrobenzene","volume":"62","author":"Shartava","year":"1999","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajh.10321","article-title":"Effects of N-acetylcysteine on dense cell formation in sickle cell disease","volume":"73","author":"Pace","year":"2003","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.020_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2174\/1381612043452901","article-title":"Induction of cytoprotective genes through Nrf2\/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases","volume":"10","author":"Chen","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.020_bib31","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.020_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/10715760290029155","article-title":"The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells","volume":"36","author":"Flier","year":"2002","journal-title":"Free Radic Res"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2003.09.110","article-title":"Induction of endogenous antioxidants and phase 2 enzymes by alpha-lipoic acid in rat cardiac H9C2 cells: protection against oxidative injury","volume":"310","author":"Cao","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.020_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s11064-007-9496-5","article-title":"Potent upregulation of glutathione and NAD(P)H:quinone oxidoreductase 1 by alpha-lipoic acid in human neuroblastoma SH-SY5Y cells: protection against neurotoxicant-elicited cytotoxicity","volume":"33","author":"Jia","year":"2008","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000098953","article-title":"Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats","volume":"79","author":"Dulundu","year":"2007","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.020_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1479-828X.2007.00787.x","article-title":"The protective effect of alpha-lipoic acid in experimental ovarian ischaemia-reperfusion injury","volume":"47","author":"Cosar","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib37","doi-asserted-by":"crossref","first-page":"F272","DOI":"10.1152\/ajprenal.00352.2007","article-title":"Effects of alpha-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats","volume":"294","author":"Bae","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.020_bib38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00595-007-3752-9","article-title":"Alpha-lipoic acid and ebselen prevent ischemia\/reperfusion injury in the rat intestine","volume":"38","author":"Guven","year":"2008","journal-title":"Surg Today"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1440-1746.2008.05673.x","article-title":"Protective effect of sulfhydryl-containing antioxidants against ischemia\/reperfusion injury of prepubertal rat intestine","volume":"24","author":"Tunc","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1191\/0960327103ht335oa","article-title":"Combined efficacies of lipoic acid and meso-2, 3-dimercaptosuccinic acid on lead-induced erythrocyte membrane lipid peroxidation and antioxidant status in rats","volume":"22","author":"Sivaprasad","year":"2003","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1191\/0960327104ht428oa","article-title":"Effect of lipoic acid on the oxidoreductive status of red blood cells in rats subject to oxidative stress by chronic administration of adriamycin","volume":"23","author":"Malarkodi","year":"2004","journal-title":"Hum Exp Toxicol"},{"issue":"4\u20135","key":"10.1016\/j.mehy.2009.12.020_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.etp.2007.11.004","article-title":"Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats","volume":"60","author":"Caylak","year":"2008","journal-title":"Exp Toxicol Pathol"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.020_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clnu.2009.01.017","article-title":"Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients","volume":"28","author":"Martins","year":"2009","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.020_bib45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome","volume":"22","author":"Morris","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.020_bib46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00277-004-0983-3","article-title":"Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease","volume":"84","author":"Schnog","year":"2005","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11883-001-0068-x","article-title":"Atherogenesis and the arginine hypothesis","volume":"3","author":"Cooke","year":"2001","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2009.12.020_bib48","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/1358836X0501000103","article-title":"ADMA: its role in vascular disease","volume":"10","author":"Cooke","year":"2005","journal-title":"Vasc Med"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","article-title":"Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism","volume":"65","author":"Schwedhelm","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.mehy.2009.12.020_bib50","first-page":"363","article-title":"Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results","volume":"93","author":"Waugh","year":"2001","journal-title":"J Natl Med Assoc"},{"issue":"19","key":"10.1016\/j.mehy.2009.12.020_bib51","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.294.19.2432-c","article-title":"Arginine metabolism, pulmonary hypertension, and sickle cell disease","volume":"294","author":"Waugh","year":"2005","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.mehy.2009.12.020_bib52","doi-asserted-by":"crossref","first-page":"18353","DOI":"10.1074\/jbc.M308160200","article-title":"Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells","volume":"279","author":"Goodwin","year":"2004","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2009.12.020_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.niox.2007.07.001","article-title":"Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle","volume":"17","author":"Flam","year":"2007","journal-title":"Nitric oxide"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.020_bib54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2141.2008.07259.x","article-title":"Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I\/II study","volume":"142","author":"Mack","year":"2008","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.mehy.2009.12.020_bib55","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.2008.598","article-title":"Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy","volume":"300","author":"Kato","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/ajcn.2008.27131","article-title":"Food sources of nitrates and nitrites: the physiologic context for potential health benefits","volume":"90","author":"Hord","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.020_bib57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.107.103523","article-title":"Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite","volume":"51","author":"Webb","year":"2008","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.020_bib58","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","article-title":"Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children","volume":"122","author":"Strouse","year":"2008","journal-title":"Pediatrics"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2009.12.020_bib59","first-page":"385","article-title":"Studies on the management and prevention of vasoocclusive crisis in sickle cell disease","volume":"15","author":"Ambrus","year":"1984","journal-title":"J Med"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2009.12.020_bib60","first-page":"277","article-title":"Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients","volume":"18","author":"Manrique","year":"1987","journal-title":"J Med"},{"issue":"10","key":"10.1016\/j.mehy.2009.12.020_bib61","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jcp.40.10.1182","article-title":"Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells","volume":"40","author":"Stuart","year":"1987","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib62","first-page":"1","article-title":"\u201cStiff red cell syndrome\u201d. A review of the treatment of sickle cell disease with pentoxifylline","volume":"24","author":"Ambrus","year":"1993","journal-title":"J Med"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.020_bib63","first-page":"466","article-title":"Treatment of homozygous sickle cell disease with pentoxifylline","volume":"91","author":"Sacerdote","year":"1999","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/j.1552-4604.1985.tb02796.x","article-title":"Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication","volume":"25","author":"Dettelbach","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2009.12.020_bib65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/asheducation-2008.1.186","article-title":"Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I","author":"Kato","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib66","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0609.2009.01210.x","article-title":"Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy","volume":"82","author":"Little","year":"2009","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11596-006-0421-y","article-title":"Effect of icariin on cyclic GMP levels and on the mRNA expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in penile cavernosum","volume":"26","author":"Jiang","year":"2006","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.020_bib68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1745-7262.2005.00066.x","article-title":"Effects of icariin on erectile function and expression of nitric oxide synthase isoforms in castrated rats","volume":"7","author":"Liu","year":"2005","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.020_bib69","first-page":"15","article-title":"Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities","volume":"5","author":"Xin","year":"2003","journal-title":"Asian J Androl"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T08:17:24Z","timestamp":1558772244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709008329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0306987709008329"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.12.020","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}